University of Cincinnati - PARENT — Cincinnati, Ohio

University of Cincinnati - PARENT is a clinical research site located in Cincinnati, Ohio, United States 45267-0502.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Cincinnati - PARENT has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Solid Tumors.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Cincinnati - PARENT?

University of Cincinnati - PARENT has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Cincinnati - PARENT conducted?

University of Cincinnati - PARENT has 2 clinical trials on record, with 2 currently active. Their work covers Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV, Solid Tumors.

Is University of Cincinnati - PARENT accredited by Crixeo Health?

University of Cincinnati - PARENT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Cincinnati - PARENT?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.